Create an email alert Loading...

1 report

BioCryst Pharmaceuticals Inc (BCRX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

227 250 193
48 pages • By GlobalData • Apr 2018
  • 09/21/2017: BIOCRYSTS RAPIVAB (PERAMIVIR INJECTION) RECEIVES FDA APPROVAL FOR A PEDIATRIC INDICATION

" This approval represents the first new influenza antiviral for pediatric use in over ## years, " said Jon P.

  • Influenza Antiviral
  • Pharmaceutical
  • United States
  • M&A
  • BioCryst Pharmaceuticals, Inc.